secwatch / observer
8-K filed February 16, 2024, 6:59 PM ET ticker CRTD CIK 0001357671
debt confidence high sentiment neutral materiality 0.70

Creatd exchanges $3.9M convertible notes and 1.5M warrants for Series F Preferred stock

Creatd, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Creatd, Inc.: Filed Certificate of Designation for Series F Preferred Stock (effective 2024-02-15).

Change
charter amendment
Effective
2024-02-15
Exact text from the filing
On February 15, 2024, the Company submitted for filing with the Secretary of State of the State of Nevada the Certificate of Designation (the “Series F Designation”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Creatd, Inc. entered into Exchange Agreement with holders of certain of the Company’s previously issued securities valued at $3.9 million of amounts owed under convertible notes and 1.5 million warrants (effective 2024-02-12).

Action
entry
Agreement
equity purchase
Counterparty
holders of certain of the Company’s previously issued securities
Value
$3.9 million of amounts owed under convertible notes and 1.5 million warrants
Effective
2024-02-12
Exact text from the filing
Beginning on February 12, 2024, Creatd, Inc., a Nevada corporation (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with holders of certain of the Company’s previously issued securities (the “Investors”), pursuant to which the Investors agreed to exchange such previously issued securities for shares of the Company’s newly created class of Series F Preferred Stock
View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Creatd, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-24-014748
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.